1.Comparison of three anaesthetic techniques of medium-flow, low-flow and low-flow with BIS monitoring for sevoflurane anaesthesia
Qiuwei FAN ; Eltringham ROGER ; Ryder SALLY
Chinese Journal of Anesthesiology 1994;0(05):-
Objective The purpose of this study was to compare the three techniques: medium-flow, low-flow and low-flow with BIS monitoring, for sevoflurane anaesthesia in terms of consumption of sevoflurane, recovery from anaesthesia, awakening time and side effects. Methods Ninety-six ASA Ⅰ - Ⅱ aged 27-51 yr undergoing elective surgery on low abdominal or low extremities under general anaesthesia were randomly divided into three groups: group A medium flow (FGF 1000 ml?min-1 ), group B low flow (FGF 500 ml?min-1 ) and group C low flow ( FGF 500 ml? min-1 ) with BIS monitoring. Sevoflurane was delivered into the circuit system from a Komesarroff vaporizer placed in-circle on the inspiration limb. In groups A and B the concentration of sevoflurane delivered was adjusted according to clinical signs of anesthesia, while in group C according to the BIS value (at 46 ?10). Before induction of anesthesia the patient was denitrogenated for 3 min with high flow rate of oxygen (6 L ?min-1 ). Anesthesia was induced with midazolam 0.03 mg?kg-1 , fentanyl 1 ?g?kg-1 , propofol 2 mg?kg-1 and vecuronium 0.1 mg?kg-1. After intubation, the patient was mechanically ventilated and PaCO2 was maintained at 35 - 45 mm Hg. Anesthesia was maintained with sevoflurane. The consumption of sevoflurane was calculated from deduction of the volume of sevoflurane left in the vaporizer from 30ml of sevoflurane added initially into the vaporizer. The duration from termination of sevoflurane administration to eye-opening and orientation and the incidence of nausea and vomiting were recorded. Results During surgery the end-tidal sevoflurane concentrations were maintained at (1.40?0.20) MAC (in group A), (1.10? 0.20) MAC (in group B) and (0.80?0.20) MAC (in group C) respectively. The volume of sevoflurane consumed was (13.3 ? 1.6) ml?h-1 (group A), (9.6 ?1.5 ) ml ? h ( group B) and (7.5?1.8)ml?h-1( group C) respectively. The time to regain consciousness were (14.3?3.3) min (group A), (10.5 ? 2.8) min (group B) and (7.5?2.6) min (group C). The times to full orientation were (24.5?6.1) min (group A), (17.4?5.5) min (group B) and (12.7 ? 4.8) min (group C). The incidence of nausea and vomiting was 14.5 % ? 2.6 % (group A), 10.1 % ?2.3 % (group B) and 7.5 % ?2.1 % (group C) . Conclusion Low-flow closed circuit anaesthesia combined with BIS monitoring has the advantages of least sevoflurane consumed, fastest recovery and least incidence of nausea and vomiting and is the best technique for sevoflurane anaesthesia.
2.Is CRT‑D superior to CRT‑P in patients with nonischemic cardiomyopathy?
Mohammed AL‑SADAWI ; Faisal ASLAM ; Michael TAO ; Shafqat SALAM ; Mahmoud ALSAIQALI ; Abhijeet SINGH ; Roger FAN ; Eric J. RASHBA
International Journal of Arrhythmia 2023;24(1):3-
Background:
Recent studies have questioned the role of implanted cardiac defibrillators (ICDs) in nonischemic cardiomyopathy (NICM). Cardiac resynchronization therapy (CRT) can be delivered by a pacemaker (CRT-P) or an ICD (CRT-D). This meta-analysis assessed the effect of CRT-P versus CRT-D on mortality in patients with NICM.
Methods:
Databases were searched for studies reporting the effect of CRT on all-cause mortality in patients with nonischemic cardiomyopathy (Ovid MEDLINE, EMBASE, Scopus, Web of Science, Google Scholar, and EBSCO CINAHL). The primary endpoint was all-cause mortality. The minimum duration of follow-up required for inclusion was one year. The search was not restricted to time or publication status.
Results:
The literature search identified 955 candidate studies, 15 studies and 22,763 patients were included. Mean follow-up was 53 months (17–100 months). CRT-D in NICM was associated with lower all-cause mortality (log HR − 0.169, SE 0.055; p = 0.002) compared to CRT-P. Heterogeneity: df = 15 (p 0.03), I2 = 43; test for overall effect: Z = − 3.043 (p = 0.002).
Conclusion
CRT-D in NICM was associated with lower all-cause mortality than CRT-P.